Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
567.75
Change Change %
-27.75 -4.66%

Updated:20 May, 2019, 12:49 PM IST

BSE
567.05
Change Change %
-29.00 -4.87%

Updated:20 May, 2019, 12:54 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
HDFC Securities
N/A
24-12-2018 Buy 710.00 980.00
N/A
Closed Medium (6M)
24-01-2019

HDFC Securities Recommends 'Buy' On Jubilant Life Sciences

According to HDFC Securities, there are several tailwinds that will ensure profitability for Jubilant Life Sciences, including a strong product pipeline and a rain in market share in venoms and radio pharma. Additionally, the planned IPO for subsidiary is expected to lead to significant debt reduction for the company, the brokerage adds.

Top